TMEFF2 and lung carcinoma: Other genes with aberrant methylation in serum DNA have been found to associate with lung cancer risk, including TMEFF2[68], RUNX3[69] and CDH13 [70], suggesting that many genes in the serum could signify lung cancer risk and that a larger profile of aberrant methylation could produce a more accurate biomarker for lung cancer risk.